HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E A Rakha Selected Research

Neoplasms (Cancer)

4/2019Expression of Lamin A/C in early-stage breast cancer and its prognostic value.
2/2008The influence of basal phenotype on the metastatic pattern of breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E A Rakha Research Topics

Disease

21Breast Neoplasms (Breast Cancer)
04/2019 - 10/2004
7Neoplasm Metastasis (Metastasis)
04/2019 - 06/2005
2Neoplasms (Cancer)
04/2019 - 02/2008
2Carcinogenesis
08/2016 - 01/2013
2Carcinoma (Carcinomatosis)
01/2015 - 06/2005
2Triple Negative Breast Neoplasms
11/2011 - 07/2008
2Lobular Carcinoma
06/2005 - 10/2004

Drug/Important Bio-Agent (IBA)

8Biological ProductsIBA
01/2016 - 03/2006
8Proteins (Proteins, Gene)FDA Link
06/2015 - 07/2008
6Biomarkers (Surrogate Marker)IBA
06/2015 - 03/2007
6Cadherins (E-Cadherin)IBA
01/2014 - 10/2004
3Hormones (Hormone)IBA
01/2014 - 11/2008
3Phenobarbital (Luminal)FDA Link
10/2013 - 11/2008
3Keratins (Keratin)IBA
05/2010 - 03/2007
2ErbB Receptors (EGF Receptor)IBA
01/2014 - 03/2007
2ProgesteroneFDA LinkGeneric
01/2014 - 03/2007
1Lamin Type A (Lamin A)IBA
04/2019
1Laminin (Merosin)IBA
08/2016
1Glycoproteins (Glycoprotein)IBA
08/2016
1Discoidin Domain ReceptorsIBA
06/2015
1SteroidsIBA
01/2014
1Neoplasm Antigens (Tumor Antigens)IBA
01/2014
1Ubiquitin-Conjugating EnzymesIBA
01/2014
1human ERBB2 proteinIBA
11/2011
1Progesterone Receptors (Progesterone Receptor)IBA
11/2011
1Caveolin 1IBA
07/2008
1Caveolin 2IBA
07/2008
1Androgen Receptors (Androgen Receptor)IBA
03/2007
1Cell Adhesion MoleculesIBA
06/2005
1Transcription Factors (Transcription Factor)IBA
10/2004

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2018 - 11/2011
2Therapeutics
01/2014 - 10/2013